RecruitingNot ApplicableNCT07511491

Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section

Effect of Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section: A Randomized Controlled Trial

Sponsor

Tanta University

Enrollment

90 participants

Start Date

Apr 11, 2026

Study Type

INTERVENTIONAL

Conditions

Prevention Shivering Cesarean Section Intravenous Ondansetron Lozenge

Summary

This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in cesarean section (CS).

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ondansetron intravenous and a drug called Ondansetron lozenge for people with cesarean section, intravenous, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGOndansetron lozenge

Patients will receive ondansetron lozenge 4 mg (Ondalenz ©), 2 hours before surgery.

DRUGOndansetron intravenous

Patients will receive 8 mg of ondansetron IV just before the surgery.

Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07511491

Related Trials

Health Education to Reduce Unnecessary Cesarean Section Among Primigravida Women

NCT07810751

Predictors of Severe Postoperative Pain Within 24 Hours After Elective Cesarean Delivery Under Spinal Anesthesia

NCT07789301

Enhanced Recovery Protocol Compliance and Quality of Recovery After Cesarean Delivery

NCT07790471

Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Sections Under Spinal Anesthesia

NCT07740577

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

NCT073825832 locations